Atlas Trials

Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli

Clinical trial NCT02333773 · COMPLETED

Trial details

NCT number
NCT02333773
Sponsor
Fuda Cancer Hospital, Guangzhou
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Liver Cancer
Start date
2015-01-01
Primary completion
2020-12-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.